• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Chemother . Characteristics and Prevalence of Sequelae after COVID-19: A Longitudinal Cohort Study

tetano

Editor, Senior Moderator
Infect Chemother


. 2025 Mar;57(1):72-80.
doi: 10.3947/ic.2024.0090. Characteristics and Prevalence of Sequelae after COVID-19: A Longitudinal Cohort Study

Se Ju Lee[SUP] #[/SUP][SUP] 1 2 [/SUP], Yae Jee Baek[SUP] #[/SUP][SUP] 3 [/SUP], Su Hwan Lee[SUP] 4 [/SUP], Jung Ho Kim[SUP] 1 [/SUP], Jin Young Ahn[SUP] 1 [/SUP], Jooyun Kim[SUP] 5 [/SUP], Ji Hoon Jeon[SUP] 5 [/SUP], Hyeri Seok[SUP] 5 [/SUP], Won Suk Choi[SUP] 5 [/SUP], Dae Won Park[SUP] 5 [/SUP], Yunsang Choi[SUP] 6 [/SUP], Kyoung-Ho Song[SUP] 6 [/SUP], Eu Suk Kim[SUP] 6 [/SUP], Hong Bin Kim[SUP] 6 [/SUP], Jae-Hoon Ko[SUP] 7 [/SUP], Kyong Ran Peck[SUP] 7 [/SUP], Jae-Phil Choi[SUP] 8 [/SUP], Jun Hyoung Kim[SUP] 9 [/SUP], Hee-Sung Kim[SUP] 9 [/SUP], Hye Won Jeong[SUP] 9 [/SUP], Jun Yong Choi[SUP] 10 [/SUP]



Affiliations
Abstract

Background: The World Health Organization has declared the end of the coronavirus disease 2019 (COVID-19) public health emergency. However, this did not indicate the end of COVID-19. Several months after the infection, numerous patients complain of respiratory or nonspecific symptoms; this condition is called long COVID. Even patients with mild COVID-19 can experience long COVID, thus the burden of long COVID remains considerable. Therefore, we conducted this study to comprehensively analyze the effects of long COVID using multi-faceted assessments.
Materials and methods: We conducted a prospective cohort study involving patients diagnosed with COVID-19 between February 2020 and September 2021 in six tertiary hospitals in Korea. Patients were followed up at 1, 3, 6, 12, 18, and 24 months after discharge. Long COVID was defined as the persistence of three or more COVID-19-related symptoms. The primary outcome of this study was the prevalence of long COVID after the period of COVID-19.
Results: During the study period, 290 patients were enrolled. Among them, 54.5 and 34.6% experienced long COVID within 6 months and after more than 18 months, respectively. Several patients showed abnormal results when tested for post-traumatic stress disorder (17.4%) and anxiety (31.9%) after 18 months. In patients who underwent follow-up chest computed tomography 18 months after COVID-19, abnormal findings remained at 51.9%. Males (odds ratio [OR], 0.17; 95% confidence interval [CI], 0.05-0.53; P=0.004) and elderly (OR, 1.04; 95% CI, 1.00-1.09; P=0.04) showed a significant association with long COVID after 12-18 months in a multivariable logistic regression analysis.
Conclusion: Many patients still showed long COVID after 18 months post SARS-CoV-2 infection. When managing these patients, the assessment of multiple aspects is necessary.

Keywords: COVID-19; Long COVID; Post-COVID-19 condition; Post-acute sequelae of SARS-CoV-2 infection.

 
Back
Top Bottom